Weekly News Recap #Phispers
Mallinckrodt, Endo merge in US$ 6.7 bn deal; Astra buys cell therapy developer EsoBiotec; Pfizer sells entire stake in Haleon

Mallinckrodt, Endo merge in US$ 6.7 bn deal; Astra buys cell therapy developer EsoBiotec; Pfizer sells entire stake in Haleon

In Phispers this week, two drugmakers emerging from bankruptcy — Mallinckrodt and Endo — are merging in order to le...

Impressions : 691

Roche buys rights to Zealand’s obesity med in US$ 5.3 bn deal; Merck wins Gardasil lawsuit, bolsters vaccine manufacturing

Roche buys rights to Zealand’s obesity med in US$ 5.3 bn deal; Merck wins Gardasil lawsuit, bolsters vaccine manufacturing

In news this week, Roche has acquired rights to develop and commercialize Zealand Pharma’s experimental obesity drug petr...

Impressions : 1049

AbbVie enters obesity race with US$ 2.23 bn deal with Denmark’s Gubra; Roche’s TNKase approved for treating strokes

AbbVie enters obesity race with US$ 2.23 bn deal with Denmark’s Gubra; Roche’s TNKase approved for treating strokes

AbbVie has forayed into the obesity treatment market with a US$ 2.23 billion licensing deal with Denmark’s Gubra for its ...

Impressions : 797

Lilly to invest US$ 27 bn in US as Trump threatens big pharma with tariffs; FDA scrambles to rehire after mass layoffs

Lilly to invest US$ 27 bn in US as Trump threatens big pharma with tariffs; FDA scrambles to rehire after mass layoffs

In the US, President Donald Trump has been putting pressure on Big Pharma to reshore or face tariffs. Eli Lilly has been the ...

Impressions : 920

US health agencies brace for more layoffs under RFK Jr; Novo alleges fraud in US$ 1.3 bn deal with KBP BioSciences

US health agencies brace for more layoffs under RFK Jr; Novo alleges fraud in US$ 1.3 bn deal with KBP BioSciences

In this week’s Phispers, we bring you news from the public health agencies in the US that have already witnessed consider...

Impressions : 849

Bain buys Mitsubishi Tanabe for US$ 3.4 bn, Novartis acquires Anthos for US$ 3.1 bn, FDA okays AbbVie-Pfizer’s new antibiotic

Bain buys Mitsubishi Tanabe for US$ 3.4 bn, Novartis acquires Anthos for US$ 3.1 bn, FDA okays AbbVie-Pfizer’s new antibiotic

In this week’s news, Bain Capital acquired Japanese pharma Mitsubishi Tanabe for US$ 3.4 billion. And Novartis acquired B...

Impressions : 1586

FDA okays Vertex’s non-opioid painkiller, Supernus’ wearable device for Parkinson’s; Sanofi, GSK plan share buybacks

FDA okays Vertex’s non-opioid painkiller, Supernus’ wearable device for Parkinson’s; Sanofi, GSK plan share buybacks

While the healthcare sector in the US was embroiled in political uncertainties over tariffs and key appointments, the country&r...

Impressions : 595

FDA approves Ozempic to treat CKD in diabetes patients; AbbVie, Neomorph ink US$ 1.64 bn deal for molecular glue degraders

FDA approves Ozempic to treat CKD in diabetes patients; AbbVie, Neomorph ink US$ 1.64 bn deal for molecular glue degraders

Novo Nordisk’s Ozempic became the first glucagon-like peptide 1 (GLP-1) drug to receive the US Food and Drug Administrati...

Impressions : 814

Trump withdraws US from WHO; Novo’s Ozempic, Wegovy among 15 new drugs chosen for price negotiations under IRA

Trump withdraws US from WHO; Novo’s Ozempic, Wegovy among 15 new drugs chosen for price negotiations under IRA

On the day Donald Trump was sworn in as the 47th President of the United States, there was a deluge of some 200 measures, which...

Impressions : 1452

J&J buys Intra-Cellular for US$ 14.6 bn; FTC exposes PBMs’ US$ 7.3 bn drug price markup scheme

J&J buys Intra-Cellular for US$ 14.6 bn; FTC exposes PBMs’ US$ 7.3 bn drug price markup scheme

The week saw the J.P. Morgan Healthcare Conference kick off with a flurry of deals. In all, deals worth over US$ 19.3 billion ...

Impressions : 803

Novo bets up to US$ 4.6 bn on AI drug development, expands deal with Valo Health; WuXi sells Irish vaccine plant to Merck

Novo bets up to US$ 4.6 bn on AI drug development, expands deal with Valo Health; WuXi sells Irish vaccine plant to Merck

As the embattled WuXi Biologics faces increasing pressure from the impending US Biosecure Act, it has decided to sell its vacci...

Impressions : 959

Lilly’s Zepbound becomes first FDA-approved therapy for sleep apnea; Novo wins nod for daily hemophilia shot

Lilly’s Zepbound becomes first FDA-approved therapy for sleep apnea; Novo wins nod for daily hemophilia shot

This week’s Phispers is a double bill with news from the last two weeks. Through much of December, the US Food and Drug A...

Impressions : 1081

Novo invests US$ 1.2 bn in new rare disease plant in Denmark; FDA approves two drugs for atopic dermatitis

Novo invests US$ 1.2 bn in new rare disease plant in Denmark; FDA approves two drugs for atopic dermatitis

As the year draws to a close, the US Food and Drug Administration (FDA) has been approving drugs at a feverish pace. It approve...

Impressions : 817

Lilly, Amgen inject billions into manufacturing; GSK’s Blenrep bests world’s top-selling myeloma drug

Lilly, Amgen inject billions into manufacturing; GSK’s Blenrep bests world’s top-selling myeloma drug

In Phispers this week, Eli Lilly announced an investment of US$ 3 billion towards building a new plant in Wisconsin (US) to me...

Impressions : 10854

Novartis snaps up PTC’s Huntington’s disease program in US$ 2.9 bn deal; Sanofi to set up insulin facility in China

Novartis snaps up PTC’s Huntington’s disease program in US$ 2.9 bn deal; Sanofi to set up insulin facility in China

In Phispers this week, we bring you news of how political changes in the US could impact the pharma industry. Big Pharma has r...

Impressions : 891

Sarepta inks US$ 11 bn RNA deal with Arrowhead; Roche expands CAR-T arsenal; Novartis buys Kate for US$ 1 bn

Sarepta inks US$ 11 bn RNA deal with Arrowhead; Roche expands CAR-T arsenal; Novartis buys Kate for US$ 1 bn

The week saw three large deals signed in promising fields. First, Sarepta Therapeutics signed a US$ 11.4 billion deal with Ar...

Impressions : 1601

Merck inks US$ 3.3 bn cancer deal with LaNova; vaccine makers’ stocks tumble after Trump picks RFK Jr to head HHS

Merck inks US$ 3.3 bn cancer deal with LaNova; vaccine makers’ stocks tumble after Trump picks RFK Jr to head HHS

This week, Merck struck a strategic US$ 3.3 billion deal with LaNova Medicines for a promising cancer drug, and also demonstr...

Impressions : 1107

Astra invests US$ 2 bn in US R&D; key AbbVie asset from US$ 8.7 bn Cerevel buy flunks phase 2 trials

Astra invests US$ 2 bn in US R&D; key AbbVie asset from US$ 8.7 bn Cerevel buy flunks phase 2 trials

This week’s Phispers is packed with news about deals. First, AstraZeneca announced a US$ 2 billion investment in the...

Impressions : 778

Astra faces probe in China; AbbVie, EvolveImmune ink potential US$ 1.4 bn deal; EC levies US$ 503 mn fine on Teva

Astra faces probe in China; AbbVie, EvolveImmune ink potential US$ 1.4 bn deal; EC levies US$ 503 mn fine on Teva

In this week’s Phispers, AstraZeneca faces a major crisis in China as its president Leon Wang is under investigation in w...

Impressions : 915

AbbVie strengthens Alzheimer’s pipeline with US$ 1.4 bn Aliada buyout; Roche expands gene therapy pact with Dyno

AbbVie strengthens Alzheimer’s pipeline with US$ 1.4 bn Aliada buyout; Roche expands gene therapy pact with Dyno

This week’s Phispers is packed with latest developments in the field of Alzheimer’s disease, owing to a conference ...

Impressions : 821

Sanofi to sell 50% stake in Opella to CD&R, to retain French workforce; AbbVie bags FDA nod for Parkinson’s therapy Vyalev

Sanofi to sell 50% stake in Opella to CD&R, to retain French workforce; AbbVie bags FDA nod for Parkinson’s therapy Vyalev

In this week’s Phispers, Sanofi has entered into exclusive talks with US private equity firm CD&R to sell a controlling 5...

Impressions : 937

Lundbeck acquires Longboard for US$ 2.6 billion; Roche’s Itovebi bags FDA nod for breast cancer

Lundbeck acquires Longboard for US$ 2.6 billion; Roche’s Itovebi bags FDA nod for breast cancer

This week’s is a double dose Phispers, as we return from a one-week break due to CPhI Worldwide. The fortnight saw severa...

Impressions : 1017

BMS med wins landmark FDA nod for schizophrenia; Sanofi’s Dupixent approved to treat COPD

BMS med wins landmark FDA nod for schizophrenia; Sanofi’s Dupixent approved to treat COPD

In this week’s Phispers, the US Food and Drug Administration (FDA) approved Bristol Myers Squibb’s groundbreaking s...

Impressions : 978

Sanofi gets two bids valuing its consumer unit at US$ 17 bn; Pfizer pulls SCD drug from market

Sanofi gets two bids valuing its consumer unit at US$ 17 bn; Pfizer pulls SCD drug from market

In news this week, Sanofi is considering the sale of its consumer health unit and has received binding bids valuing the divisi...

Impressions : 1217

FDA panel votes against Intercept’s liver med Ocaliva; Lilly’s Ebglyss wins approval for eczema

FDA panel votes against Intercept’s liver med Ocaliva; Lilly’s Ebglyss wins approval for eczema

Intercept Pharmaceuticals faced a major setback as a US Food and Drug Administration (FDA) panel voted against the confirmato...

Impressions : 1042

GSK’s COPD, long-acting asthma drugs score late-stage wins;  Novo’s weight-loss drug Saxenda found to be safe in kids

GSK’s COPD, long-acting asthma drugs score late-stage wins; Novo’s weight-loss drug Saxenda found to be safe in kids

GSK scored a significant late-stage win with its asthma drug Nucala in treating chronic obstructive pulmonary disease (COPD). I...

Impressions : 786

FDA approves Emergent’s smallpox vaccine for mpox; Lilly inks up to US$ 1 bn deal with Haya to target obesity

FDA approves Emergent’s smallpox vaccine for mpox; Lilly inks up to US$ 1 bn deal with Haya to target obesity

This week saw the US Food and Drug Administration (FDA) respond to the global monkeypox (mpox) public health emergency by expan...

Impressions : 1126

Lilly, Pfizer move to sell drugs directly to consumers; blast at Indian drug factory kills 17

Lilly, Pfizer move to sell drugs directly to consumers; blast at Indian drug factory kills 17

An Indian factory that makes drugs for export to the US and other Western nations saw an explosion, caused by a chemical solven...

Impressions : 1612